Spyglass Pharma, Inc.

SGP

Financials

10-QQ2 ended 06/30/2608/06/2610-QQ1 ended 03/31/2605/14/2610-KFY 202503/26/26

Disclosures

8-KCurrent report10/19/268-KCurrent report10/01/268-KCurrent report08/06/268-KCurrent report05/14/268-KCurrent report03/26/26

Prospectuses and Registrations

424B4Prospectus02/06/26S-8Registration of securities for employees02/06/26S-1/ARegistration statement (amended)01/29/26S-1Registration statement (IPO)01/16/26

Proxies

No matching filings.

Ownership

SC 13DBeneficial ownership02/17/26SC 13GBeneficial ownership02/17/26SC 13DBeneficial ownership02/13/26SC 13DBeneficial ownership02/13/26SC 13GBeneficial ownership02/13/26

Other

8-A12B8-A12B02/05/26CERTCEO/CFO certification02/05/26EFFECTRequest for effectiveness01/30/26CORRESPCorrespondence with the SEC01/29/26CORRESPCorrespondence with the SEC01/29/26